Skip to main content

Praxbind Side Effects

Generic name: idarucizumab

Medically reviewed by Last updated on Jun 7, 2023.

Note: This document contains side effect information about idarucizumab. Some dosage forms listed on this page may not apply to the brand name Praxbind.

Applies to idarucizumab: intravenous solution.

Serious side effects of Praxbind

Along with its needed effects, idarucizumab (the active ingredient contained in Praxbind) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking idarucizumab:

Incidence not known

For Healthcare Professionals

Applies to idarucizumab: intravenous solution.


The most common adverse reactions were hypokalemia, delirium, constipation, pyrexia, pneumonia, and headache.[Ref]


Common (1% to 10%): Thrombotic events[Ref]


Common (1% to 10%): Hypokalemia[Ref]


Common (1% to 10%): Delirium[Ref]


Common (1% to 10%): Constipation, nausea[Ref]


Common (1% to 10%): Pyrexia[Ref]


Common (1% to 10%): Pneumonia

Frequency not reported: Bronchospasm, hyperventilation[Ref]

Nervous system

Common (1% to 10%): Headache[Ref]


Frequency not reported: Rash, pruritus[Ref]


Frequency not reported: Hypersensitivity reactions[Ref]


1. Cerner Multum, Inc. UK Summary of Product Characteristics.

2. Product Information. Praxbind (idarucizumab). Boehringer Ingelheim. 2016.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.